Why Johnson & Johnson (JNJ) is Poised to Beat Earnings Estimates Again

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Johnson & Johnson (JNJ) , which belongs to the Zacks Large Cap Pharmaceuticals industry, could be a great candidate to consider.This world's biggest maker of health care products has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 5.96%.For the mos ...